Protagonist Therapeutics (PTGX) Prepaid Assets (2015 - 2026)
Protagonist Therapeutics (PTGX) reported Prepaid Assets of $1.1 million for Q1 2026, down 87.39% on a YoY basis from $8.7 million in Q1 2025, and up 3.11% sequentially from $1.1 million in Q4 2025.
Protagonist Therapeutics (PTGX) Prepaid Assets (2015 - 2026) Analysis & Trends
Protagonist Therapeutics (PTGX) has 12 years of Prepaid Assets data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 87.39% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 87.39% YoY), and the FY2025 full-year result was $1.1 million, down 86.27% from the prior year.
- Prepaid Assets improved to $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $8.7 million in Q2 2025 to a low of $65000.0 in Q3 2023.
- A 5-year average of $2.6 million and a median of $1.3 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets tumbled 98.67% in 2023 and soared 10068.42% in 2024, its largest moves.
- Tracing PTGX's Prepaid Assets over 5 years: stood at $5.7 million in 2022, then tumbled by 98.67% to $76000.0 in 2023, then soared by 10068.42% to $7.7 million in 2024, then tumbled by 86.27% to $1.1 million in 2025, then grew by 3.11% to $1.1 million in 2026.
- Business Quant data shows PTGX's Prepaid Assets at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $191000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Protagonist Therapeutics | 8.81 Bn | 8.81 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 191,000.00 |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 8.68 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 76,000.00 |
| Sep 30, 2023 | 65,000.00 |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 1.49 Mn |
| Dec 31, 2022 | 5.71 Mn |
| Sep 30, 2022 | 436,000.00 |
| Jun 30, 2022 | 1.79 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 1.52 Mn |
| Sep 30, 2021 | 8.88 Mn |
| Jun 30, 2021 | 7.68 Mn |